Back to search
FDAFDA · Food and drugs·Recall number D-0226-2026

Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02

Published December 17, 2025 · Recall initiated: November 14, 2025

Summary

FDA records drug Class II recall D-0226-2026, published December 17, 2025 and initiated November 14, 2025. Recalling firm: Cipla USA, Inc.; Status: Ongoing; Reported quantity: 12,576 bottles; Lot: Lot 5PB0183, exp 1/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

What to do

Voluntary: Firm initiated · Letter

Get an email if CINACALCET has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CINACALCET
Manufacturer
Cipla USA, Inc.
Distributor
Nationwide in the US
Lot
Lot 5PB0183, exp 1/31/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02 recalled?

Yes. FDA published recall D-0226-2026 on December 17, 2025. Reported hazard: CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CINACALCET.